In the present study, we have extended our previous study [21] by revealing that Pim kinases are involved downstream of the robust STAT5 activation in acquisition of the resistance to PI3K/Akt inhibitors by protecting the mTORC1/Mcl-1 pathway in FLT3-ITD-expressing AML cells. Here, MCL1 is linked to acute myeloid leukemia.